- Home
- PSHG vs CRIS Comparison
PSHG vs CRIS Comparison
Compare PSHG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSHG
- CRIS
- Stock Information
- Founded
- PSHG 2010
- CRIS 2000
- Country
- PSHG Greece
- CRIS United States
- Employees
- PSHG N/A
- CRIS N/A
- Industry
- PSHG Marine Transportation
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSHG Consumer Discretionary
- CRIS Health Care
- Exchange
- PSHG Nasdaq
- CRIS Nasdaq
- Market Cap
- PSHG 22.8M
- CRIS 21.3M
- IPO Year
- PSHG N/A
- CRIS 2000
- Fundamental
- Price
- PSHG $1.86
- CRIS $1.83
- Analyst Decision
- PSHG
- CRIS Strong Buy
- Analyst Count
- PSHG 0
- CRIS 2
- Target Price
- PSHG N/A
- CRIS $16.50
- AVG Volume (30 Days)
- PSHG 85.0K
- CRIS 61.6K
- Earning Date
- PSHG 07-30-2025
- CRIS 08-05-2025
- Dividend Yield
- PSHG N/A
- CRIS N/A
- EPS Growth
- PSHG 5.84
- CRIS N/A
- EPS
- PSHG 1.56
- CRIS N/A
- Revenue
- PSHG $84,042,000.00
- CRIS $11,405,000.00
- Revenue This Year
- PSHG N/A
- CRIS N/A
- Revenue Next Year
- PSHG $23.25
- CRIS $9.52
- P/E Ratio
- PSHG $1.20
- CRIS N/A
- Revenue Growth
- PSHG N/A
- CRIS 12.24
- 52 Week Low
- PSHG $1.31
- CRIS $1.02
- 52 Week High
- PSHG $2.34
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- PSHG 56.01
- CRIS 53.34
- Support Level
- PSHG $1.76
- CRIS $1.65
- Resistance Level
- PSHG $1.92
- CRIS $1.79
- Average True Range (ATR)
- PSHG 0.11
- CRIS 0.13
- MACD
- PSHG 0.01
- CRIS 0.02
- Stochastic Oscillator
- PSHG 79.31
- CRIS 84.85
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.